Cencora Current Ratio 2010-2025 | COR
Current and historical current ratio for Cencora (COR) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Cencora current ratio for the three months ending March 31, 2025 was 0.87.
| Cencora Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $46.54B | $53.33B | 0.87 |
| 2024-12-31 | $49.99B | $54.51B | 0.92 |
| 2024-09-30 | $47.72B | $54.28B | 0.88 |
| 2024-06-30 | $47.31B | $52.97B | 0.89 |
| 2024-03-31 | $44.16B | $49.76B | 0.89 |
| 2023-12-31 | $44.86B | $50.77B | 0.88 |
| 2023-09-30 | $42.80B | $48.83B | 0.88 |
| 2023-06-30 | $40.99B | $46.78B | 0.88 |
| 2023-03-31 | $39.99B | $45.07B | 0.89 |
| 2022-12-31 | $40.71B | $44.76B | 0.91 |
| 2022-09-30 | $39.59B | $43.48B | 0.91 |
| 2022-06-30 | $39.75B | $43.15B | 0.92 |
| 2022-03-31 | $39.41B | $42.80B | 0.92 |
| 2021-12-31 | $39.38B | $41.61B | 0.95 |
| 2021-09-30 | $38.80B | $41.36B | 0.94 |
| 2021-06-30 | $37.26B | $39.59B | 0.94 |
| 2021-03-31 | $35.47B | $33.00B | 1.08 |
| 2020-12-31 | $34.70B | $35.04B | 0.99 |
| 2020-09-30 | $33.06B | $33.85B | 0.98 |
| 2020-06-30 | $29.92B | $30.63B | 0.98 |
| 2020-03-31 | $31.18B | $32.11B | 0.97 |
| 2019-12-31 | $28.96B | $30.63B | 0.95 |
| 2019-09-30 | $28.13B | $29.58B | 0.95 |
| 2019-06-30 | $27.40B | $28.79B | 0.95 |
| 2019-03-31 | $27.62B | $29.21B | 0.95 |
| 2018-12-31 | $27.48B | $29.35B | 0.94 |
| 2018-09-30 | $25.89B | $27.87B | 0.93 |
| 2018-06-30 | $26.40B | $28.10B | 0.94 |
| 2018-03-31 | $26.40B | $28.09B | 0.94 |
| 2017-12-31 | $25.30B | $26.74B | 0.95 |
| 2017-09-30 | $24.30B | $26.82B | 0.91 |
| 2017-06-30 | $23.68B | $25.75B | 0.92 |
| 2017-03-31 | $23.49B | $25.53B | 0.92 |
| 2016-12-31 | $23.08B | $25.54B | 0.90 |
| 2016-09-30 | $22.85B | $25.28B | 0.90 |
| 2016-06-30 | $21.46B | $24.00B | 0.89 |
| 2016-03-31 | $22.07B | $23.77B | 0.93 |
| 2015-12-31 | $20.36B | $24.02B | 0.85 |
| 2015-09-30 | $20.33B | $21.58B | 0.94 |
| 2015-06-30 | $19.90B | $21.12B | 0.94 |
| 2015-03-31 | $19.56B | $20.23B | 0.97 |
| 2014-12-31 | $20.15B | $20.81B | 0.97 |
| 2014-09-30 | $16.80B | $17.25B | 0.97 |
| 2014-06-30 | $15.89B | $16.34B | 0.97 |
| 2014-03-31 | $15.76B | $16.50B | 0.96 |
| 2013-12-31 | $15.23B | $15.83B | 0.96 |
| 2013-09-30 | $14.39B | $14.87B | 0.97 |
| 2013-06-30 | $12.14B | $12.44B | 0.98 |
| 2013-03-31 | $11.73B | $12.04B | 0.97 |
| 2012-12-31 | $11.02B | $11.44B | 0.96 |
| 2012-09-30 | $11.06B | $11.27B | 0.98 |
| 2012-06-30 | $11.17B | $10.95B | 1.02 |
| 2012-03-31 | $11.60B | $10.92B | 1.06 |
| 2011-12-31 | $11.96B | $11.30B | 1.06 |
| 2011-09-30 | $11.38B | $10.88B | 1.05 |
| 2011-06-30 | $11.12B | $10.01B | 1.11 |
| 2011-03-31 | $10.96B | $9.95B | 1.10 |
| 2010-12-31 | $10.43B | $9.64B | 1.08 |
| 2010-09-30 | $10.75B | $9.91B | 1.09 |
| 2010-06-30 | $10.34B | $9.49B | 1.09 |
| 2010-03-31 | $10.17B | $9.43B | 1.08 |
| 2009-12-31 | $9.92B | $9.24B | 1.07 |
| 2009-09-30 | $9.95B | $9.48B | 1.05 |
| 2009-06-30 | $9.14B | $8.59B | 1.06 |
| 2009-03-31 | $9.01B | $8.48B | 1.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $57.416B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.424B | 27.27 |
| CVS Health (CVS) | United States | $85.300B | 10.60 |
| Elevance Health (ELV) | United States | $78.589B | 10.14 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.088B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.920B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.673B | 0.00 |
| Solventum (SOLV) | United States | $13.582B | 14.38 |
| CochLear (CHEOY) | Australia | $12.960B | 0.00 |
| ICON (ICLR) | Ireland | $12.122B | 11.27 |
| Revvity (RVTY) | United States | $11.941B | 20.55 |
| Viatris (VTRS) | United States | $10.939B | 3.76 |
| Avantor (AVTR) | United States | $9.458B | 13.74 |
| Medpace Holdings (MEDP) | United States | $9.240B | 24.54 |
| HealthEquity (HQY) | United States | $8.834B | 38.70 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.717B | 15.12 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.752B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.910B | 28.92 |
| BrightSpring Health Services (BTSG) | United States | $3.889B | 35.68 |
| Sotera Health (SHC) | United States | $3.334B | 18.94 |
| Surgery Partners (SGRY) | United States | $2.839B | 36.92 |
| Alignment Healthcare (ALHC) | United States | $2.685B | 0.00 |
| Concentras Parent (CON) | United States | $2.635B | 15.23 |
| GeneDx Holdings (WGS) | United States | $2.614B | 100.67 |
| Organon (OGN) | United States | $2.589B | 2.75 |
| PACS (PACS) | United States | $2.003B | 0.00 |
| Ardent Health (ARDT) | United States | $1.915B | 8.16 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.812B | 13.76 |
| GoodRx Holdings (GDRX) | United States | $1.682B | 33.64 |
| Teladoc Health (TDOC) | United States | $1.454B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.259B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.184B | 9.01 |
| CareDx (CDNA) | United States | $1.071B | 16.73 |
| Agilon Health (AGL) | United States | $1.006B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.86 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| Embecta (EMBC) | United States | $0.603B | 4.06 |
| InnovAge Holding (INNV) | United States | $0.602B | 0.00 |
| LifeMD (LFMD) | United States | $0.568B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.481B | 0.00 |
| Omada Health (OMDA) | $0.480B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| SBC Medicals (SBC) | United States | $0.463B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 31.88 |
| So-Young (SY) | China | $0.330B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.328B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.305B | 0.00 |
| Beauty Health (SKIN) | United States | $0.287B | 0.00 |
| Oncology Institute (TOI) | United States | $0.225B | 0.00 |
| DocGo (DCGO) | United States | $0.161B | 26.33 |
| Pheton Holdings (PTHL) | China | $0.126B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.094B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |